Odomzo (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the Odomzo drug offered from Sun Pharma Global FZE. This Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
NON-PROPRIETARY NAME: | sonidegib |
SUBSTANCE NAME: | SONIDEGIB PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-09-21 |
END MARKETING DATE: | 0000-00-00 |
Odomzo HUMAN PRESCRIPTION DRUG Details:
Item Description | Odomzo from Sun Pharma Global FZE |
LABELER NAME: | Sun Pharma Global FZE |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2017-09-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47335-303_4133d373-2c2d-4500-9642-dec58b1af4ce |
PRODUCT NDC: | 47335-303 |
APPLICATION NUMBER: | NDA205266 |
Other SONIDEGIB PHOSPHATE Pharmaceutical Manufacturers / Labelers: